Xgeva® Vial (denosumab 120 mg / 1.7 ml)
$495.00
| Prevention of skeletal related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with multiple myeloma and in adults with bone metastases from solid tumours.Treatment of adult and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity. |
Reviews
Write a review
The product has no reviews
Leave your review
